In clinical studies, DPP-4 inhibitors showimproved efficacy over time [81].Therefore, at present, the inhibitors of DPP-4 are under development inpreclinical and clinical studies as potential drugs for the treatment of type 2diabetes. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.